We have shown that the development and progression of AT8-positive tau pathology in this study occurs longitudinally in animals injected with AD tau seeds but exhibit more pathology in APP.PS1 animals compared to wild-type animals. The gene discussed is MAPT; the disease is Alzheimer disease.